New tool aims to personalize breast cancer screening for thousands of women
NCT ID NCT04996316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a tool called MammoScreen, a simple questionnaire that helps identify women at average or increased risk for breast cancer. The goal is to see if using this tool in clinics leads to more appropriate screening referrals. About 1,141 women aged 40 to 74 who use MyChart and read English will take part. The study does not test a treatment but aims to improve how breast cancer risk is assessed and managed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phone-Based navigation could boost breast cancer detection in kenya
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a sticky film shield breast cancer patients from radiation burns in tropical heat?
- Can a simpler, cheaper method for marking breast tumors work as well as ultrasound?
- Could adding chemo help older breast cancer patients live longer? a major trial investigates.